Accéder au contenu
Merck

A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells.

Scientific reports (2014-11-14)
Bin Liu, Bin Lin, Xiaoyu Tan, Jian Liang, Shixing Wu, Jie Liu, Qingyu Zhang, Runzhi Zhu
RÉSUMÉ

Reactive oxygen species (ROS) and cellular oxidant stress are considered inducers of carcinogenesis. However, the association of ROS with cancer is both complex and, at times, paradoxical. We assessed the effects of dihydromyricetin (DHM) on the induction of ROS accumulation and on the activation of the mitochondrial signaling pathway in human hepatoma HepG2 cells. The results indicated that DHM could reduce ROS accumulation in a concentration-dependent manner. Additionally, with increasing concentrations of DHM, the expression of proteins that participate in the cell apoptosis program increased in a concentration-dependent manner. Furthermore, we found that a low dose of H2O2 (10 nM) could reverse DHM-induced cell apoptosis. We observed the following critical issues: first, the cellular redox balance is vital in DHM-induced apoptosis of human hepatocellular carcinoma (HCC) cells, and second, ROS could function as a redox-active signaling messenger to determine DHM-induced cell apoptosis. In this study, we demonstrated that low levels of ROS are also critical for the function of HCC cells.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
DL-Dithiothréitol solution, BioUltra, for molecular biology, ~1 M in H2O
Supelco
DL-Dithiothréitol solution, 1 M in H2O
Sigma-Aldrich
L-Glutathion réduit, suitable for cell culture, BioReagent, ≥98.0%, powder
Sigma-Aldrich
L-Glutathion réduit, ≥98.0%
Supelco
L-Glutathion réduit, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Glutathion réduit, BioXtra, ≥98.0%
L-Glutathion réduit, European Pharmacopoeia (EP) Reference Standard